Medtronic's SynchroMed II implantable painkiller pump undergoes its second class 1 recall this year over reports of defective batteries.
Medtronic Inc.'s (NYSE:MDT) urgent update last month turned into a second class I recall for its SynchroMed II implantable drug infusion pumps over reports that the devices may have defective batteries that can lead to sudden failure.
The SynchroMed system includes an implanted catheter and pump infusion system that stores and delivers medication to a specific site. There are about 140,000 pumps in use worldwide.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...